← Back to Search

Tailored Light Therapy for Dementia

N/A
Recruiting
Led By Mariana G Figueiro, PhD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mild to moderate Alzheimer's disease and related dementia (ADRD)
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline (week 0) and intervention (week 4)
Awards & highlights

Study Summary

This trial shows that tailored light treatment can improve sleep, reduce depression and reduce agitation in people with Alzheimer's disease and related dementia.

Who is the study for?
This trial is for individuals with mild to moderate Alzheimer's disease and related dementia. It's not suitable for those who are blind, have major organ failure or illness, a history of head injury, uncontrolled hypertension or diabetes, use sleep aid medicine, or have obstructing cataracts or macular degeneration.Check my eligibility
What is being tested?
The study tests whether tailored light treatment can improve sleep efficiency, reduce depression symptoms, and lessen agitation in people with dementia. Participants will receive either an active light intervention designed just for them or a placebo-like inactive one.See study design
What are the potential side effects?
Since the trial involves light therapy rather than medication, side effects may be minimal but could include potential discomfort from the light exposure such as eye strain or headache.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with mild to moderate Alzheimer's or related dementia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline (week 0) and intervention (week 4)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline (week 0) and intervention (week 4) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Agitation
Depression
Sleep Disturbance
Secondary outcome measures
Actigraphy
Activity of Daily Living
Light/dark patterns

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active InterventionActive Control1 Intervention
Light levels, primary and secondary measurements are obtained after a 4-week intervention period where active lighting is experienced by patients.
Group II: Inactive interventionPlacebo Group1 Intervention
Light levels, primary and secondary measurements are obtained after a 4-week intervention period where an inactive lighting is experienced by patients

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,692 Previous Clinical Trials
28,027,169 Total Patients Enrolled
36 Trials studying Depression
28,308 Patients Enrolled for Depression
Icahn School of Medicine at Mount SinaiLead Sponsor
871 Previous Clinical Trials
527,206 Total Patients Enrolled
34 Trials studying Depression
4,324 Patients Enrolled for Depression
Mariana G Figueiro, PhDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
2 Previous Clinical Trials
76 Total Patients Enrolled

Media Library

Tailored Light Treatment Clinical Trial Eligibility Overview. Trial Name: NCT01816152 — N/A
Depression Research Study Groups: Active Intervention, Inactive intervention
Depression Clinical Trial 2023: Tailored Light Treatment Highlights & Side Effects. Trial Name: NCT01816152 — N/A
Tailored Light Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT01816152 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment capacity of this experiment?

"Affirmative. Evidence found on clinicaltrials.gov indicates that this investigation, which was initially published on January 1st 2020, is currently enrolling volunteers. 45 individuals need to be recruited from 5 different sites."

Answered by AI

Is this trial still recruiting participants?

"Affirmative. According to the information available on clinicaltrials.gov, this medical experiment is now open for enrolment and was initially posted in 2020. The trial necessitates 45 participants from 5 distinct sites, with its most recent update taking place at the end of 2022."

Answered by AI

How many locales are hosting this clinical trial?

"Five trial sites are enrolling patients for this clinical study, with Hawthorne Ridge in East Greenbush, Icahn School of Medicine at Mount Sinai in Troy and Teresian House in New york all participating. Additionally, there are another 5 medical centres actively recruiting participants."

Answered by AI
Recent research and studies
~9 spots leftby Jun 2025